FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T22:23:56.281Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T22:23:56.281Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T22:23:56.281Z. Latest historical point 2024-01-09. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T22:23:56.281Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T22:23:56.281Z. Latest historical point 2024-01-09. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products.
Drug Manufacturers - Specialty & Generic · Leamington, ON
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
Product / business disclosures (FY 2026)
2026-05-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Cannabis Segment$352.31M
Distribution Revenue$327.24M
Beverage Alcohol Business$265.46M
Wellness Business$65.89M
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Reviewed labels link to their filing; other labels are unverified FMP source labels.
EMEA$445.70M
UNITED STATES$242.39M
CANADA$215.66M
Rest of World$11.71M
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$281.71M
vs Estimate
$246.30M
Beat
TLRY Analyst Ratings
Consensus Rating
Hold
Based on 8 analysts
Strong Buy
0
Buy
2
Hold
3
Sell
0
Strong Sell
0
Average Price Target
$7.16
+89.3% upside
Low
$4.00
Current
$3.78
High
$17.00
TLRY Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
Period
Low
Avg
High
# Analysts
Quarter ending Aug 2026
$-0.29
$-0.18
$-0.09
2
Quarter ending Nov 2026
$-0.26
$-0.18
$-0.07
2
Quarter ending Feb 2027
$-0.18
$-0.17
$-0.16
1
Quarter ending May 2027
$-0.01
$-0.01
$-0.01
1
Annual
Period
Low
Avg
High
# Analysts
FY 2027
$-0.98
$-0.50
$-0.14
3
FY 2028
$-0.92
$-0.25
$0.04
3
Revenue Estimates
Quarterly
Period
Low
Avg
High
# Analysts
Quarter ending Aug 2026
$259.02M
$266.57M
$274.11M
6
Quarter ending Nov 2026
$263.61M
$270.36M
$274.91M
6
Quarter ending Feb 2027
$251.85M
$265.68M
$273.41M
3
Quarter ending May 2027
$298.06M
$314.42M
$323.58M
4
Annual
Period
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
